But the first time I saw mine? At 43 years old. This was after three babies (my kids are 12, 12 and 8), and while working the ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

There's no doubt that exercise does a body good. Regular activity not only strengthens muscles but can bolster our bones, ...

Sarepta has stopped developing SRP-5051, its exon 51-skipping therapy for Duchenne MD, due to long-term safety concerns and ...

Regular activity not only strengthens muscles but can bolster our bones, blood vessels, and immune system. MIT engineers have now found that exercise can also have benefits at the level of individual ...

Investors consider Dyne Therapeutics' treatments for muscle diseases and strong cash position as a speculative Buy ...

Specific mutations in the DMD gene influence how long patients retain the ability to walk, even when treated with ...

Elevidys sales have increased since the FDA made a controversial choice to expand the therapy's use. Meanwhile, Sarepta is ...

The US biopharma will discontinue development of the Exondys 51 (eteplirsen) follow up treatment to focus on other treatment ...